prof. MUDr. Jaroslav Štěrba, Ph.D.
Vice-Dean for Professional Education, Faculty of Medicine
correspondence Address:
Černopolní 212/9, 662 63 Brno
phone: | +420 532 23 4600, 4614 |
---|---|
e‑mail: |
Total number of publications: 472
2023
-
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen A Nonrandomized Controlled Trial
JAMA ONCOLOGY, year: 2023, volume: 9, edition: 12, DOI
-
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
Scientific reports, year: 2023, volume: 13, edition: 1, DOI
-
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
Scientific Reports, year: 2023, volume: 13, edition: 1, DOI
2022
-
Dynamika středního objemu erytrocytů (MCV) jako potenciálního biomarkeru compliance a terapeutické toxicity sunitinibu u onkologických pacientů
Year: 2022, type:
-
European regulatory strategy for supporting childhood cancer therapy developments
European Journal of Cancer, year: 2022, volume: 177, edition: December 2022, DOI
-
Final results of the Choroid Plexus Tumor study CPT-SIOP-2000
Journal of Neuro-Oncology, year: 2022, volume: 156, edition: 3, DOI
-
Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
JCO PRECISION ONCOLOGY, year: 2022, volume: 6, edition: June 2022, DOI
-
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
European Journal of Cancer, year: 2022, volume: 160, edition: January 2022, DOI
-
PredictSNP Onco 1.0
Year: 2022
-
Prognostic factors and seizure outcome in posterior reversible encephalopathy syndrome (PRES) in children with malignancies.
Year: 2022, type: Conference abstract